Clinical trial
RCT for the Effect of Early Administration of Vasoactive Substances When Combined With Endoscopic Treatment in Acute Gastro-esophageal Variceal Bleeds: Comparisons Among Terlipressin, Somatostatin, and Octreotide
NCT00966355 is registered in ClinicalTrials.gov with Korea University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RCT for the Effect of Early Administration of Vasoactive Substances When Combined With Endoscopic Treatment in Acute Gastro-esophageal Variceal Bleeds: Comparisons Among Terlipressin, Somatostatin, and Octreotide
- Lead sponsor
- Korea University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- May 31, 2010
- Enrollment
- 1,034 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
variceal bleeding, cirrhosis